ATE133070T1 - Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms - Google Patents

Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms

Info

Publication number
ATE133070T1
ATE133070T1 AT91305729T AT91305729T ATE133070T1 AT E133070 T1 ATE133070 T1 AT E133070T1 AT 91305729 T AT91305729 T AT 91305729T AT 91305729 T AT91305729 T AT 91305729T AT E133070 T1 ATE133070 T1 AT E133070T1
Authority
AT
Austria
Prior art keywords
ogp
cold syndrome
oxygermylpropionic acid
treat cold
weight
Prior art date
Application number
AT91305729T
Other languages
English (en)
Inventor
Kiichi C O Sanwa Kagaku Sawai
Higashi-Ku
Masayasu C O Sanwa Kaga Kurono
Takahiko C O Sanwa Kaga Mitani
Naohisa C O Sanwa Kag Ninomiya
Original Assignee
Sanwa Kagaku Kenkyusho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co filed Critical Sanwa Kagaku Kenkyusho Co
Application granted granted Critical
Publication of ATE133070T1 publication Critical patent/ATE133070T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91305729T 1990-07-04 1991-06-25 Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms ATE133070T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2176679A JPH0466530A (ja) 1990-07-04 1990-07-04 ３―オキシゲルミルプロピオン酸作用安定化錠剤及び該錠剤の組成物を主成分とする風邪症侯群治療剤

Publications (1)

Publication Number Publication Date
ATE133070T1 true ATE133070T1 (de) 1996-02-15

Family

ID=16017829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91305729T ATE133070T1 (de) 1990-07-04 1991-06-25 Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms

Country Status (4)

Country Link
EP (1) EP0465091B1 (de)
JP (1) JPH0466530A (de)
AT (1) ATE133070T1 (de)
DE (1) DE69116452T2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55122717A (en) * 1979-03-15 1980-09-20 Asai Gerumaniumu Kenkyusho:Kk Interferon inducer
JPS61145115A (ja) * 1984-12-18 1986-07-02 Asai Gerumaniumu Kenkyusho:Kk 塵肺症患者用風邪症候群予防剤
JPH0662407B2 (ja) * 1984-12-25 1994-08-17 株式会社三和化学研究所 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤

Also Published As

Publication number Publication date
DE69116452D1 (de) 1996-02-29
DE69116452T2 (de) 1996-05-30
EP0465091B1 (de) 1996-01-17
EP0465091A1 (de) 1992-01-08
JPH0466530A (ja) 1992-03-02

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
ATE71843T1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE69210802D1 (de) Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ATE128865T1 (de) Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit.
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
HUT46046A (en) Process for producing compounds with nootropic effect and pharmaceutics comprising these as active ingredient
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ATE169217T1 (de) Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
MC1930A1 (fr) Produit antiviral
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
ATE133070T1 (de) Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties